Abernathy MacGregor and Kekst are engaged in a proxy showdown over publicly traded nutritional supplement company Omega Protein Corp.

Omega ProteinHouston-based Omega is facing a proxy contest from hedge fund Wynnefield Capital, which is offering two candidates for Omega's board. Wynnefield says it wants to "reverse the company's trajectory of capital loss."

The proxy contest has turned particularly sour late last week when Wynnefield sued Omega in Nevada state court to obtain shareholder information, a move dubbed a "blatant public relations effort to distract stockholers" by Omega.

Omega is working with Abernathy MacGregor, where executive VP Sydney Isaacs is advising Omega out of Houston. The company has also engaged D.F. King & Co. for proxy solicitation.

On the flip side, Wynnefield Capital is working with Kekst on the PR front. Kekst managing directors Mark Semer and Danniel Yunger are on the Wynnefield team.

Omega's annual meeting is set for June 28. First quarter revenues were up 18% to $84.8M with net income of $8.4M.